JP2019508175A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508175A5
JP2019508175A5 JP2018548751A JP2018548751A JP2019508175A5 JP 2019508175 A5 JP2019508175 A5 JP 2019508175A5 JP 2018548751 A JP2018548751 A JP 2018548751A JP 2018548751 A JP2018548751 A JP 2018548751A JP 2019508175 A5 JP2019508175 A5 JP 2019508175A5
Authority
JP
Japan
Prior art keywords
solution
self
assembling peptide
pancreatic fistula
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018548751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/000366 external-priority patent/WO2017158432A1/en
Publication of JP2019508175A publication Critical patent/JP2019508175A/ja
Publication of JP2019508175A5 publication Critical patent/JP2019508175A5/ja
Pending legal-status Critical Current

Links

JP2018548751A 2016-03-18 2017-03-17 膵液瘻の閉鎖 Pending JP2019508175A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662310124P 2016-03-18 2016-03-18
US62/310,124 2016-03-18
PCT/IB2017/000366 WO2017158432A1 (en) 2016-03-18 2017-03-17 Pancreatic fistula occlusion

Publications (2)

Publication Number Publication Date
JP2019508175A JP2019508175A (ja) 2019-03-28
JP2019508175A5 true JP2019508175A5 (enExample) 2020-04-23

Family

ID=58672629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018548751A Pending JP2019508175A (ja) 2016-03-18 2017-03-17 膵液瘻の閉鎖

Country Status (9)

Country Link
US (1) US20200078489A1 (enExample)
EP (1) EP3429646A1 (enExample)
JP (1) JP2019508175A (enExample)
CN (1) CN109152861A (enExample)
AU (1) AU2017235871A1 (enExample)
BR (1) BR112018068838A2 (enExample)
CL (1) CL2018002644A1 (enExample)
MX (1) MX2018011120A (enExample)
WO (1) WO2017158432A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109152868A (zh) 2016-03-18 2019-01-04 立美基股份有限公司 防止生物组织粘连
JP6912953B2 (ja) * 2016-06-27 2021-08-04 三洋化成工業株式会社 体液漏出防止剤
JP7437315B2 (ja) * 2018-10-05 2024-02-22 学校法人 久留米大学 腸管における潰瘍または瘻孔の治療または予防のための医薬組成物
ES3060370T3 (en) * 2020-02-28 2026-03-26 Menicon Co Ltd Digestive fluid leak preventative material and organ protective material against digestion by digestive fluid
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2427565T3 (es) * 2005-04-25 2013-10-31 Massachusetts Institute Of Technology Péptidos autoensambladores para promover la hemostasia
WO2009049022A1 (en) * 2007-10-10 2009-04-16 Ore Pharmaceuticals Inc. Method for treatment of pancreatitis
EP3238749B2 (en) * 2008-10-06 2025-06-04 3-D Matrix, Ltd. Tissue plug
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage
CN105342984A (zh) * 2014-08-21 2016-02-24 中国人民解放军总医院 一种用于治疗急性胰腺炎的可注射温敏凝胶制剂

Similar Documents

Publication Publication Date Title
Patrulea et al. An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections
Vigani et al. Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes
Ibraheem et al. Administration strategies for proteins and peptides
US10040821B2 (en) Compositions containing HC-HA/PTX3 complexes and methods of use thereof
JP2019533722A5 (enExample)
JP2011502479A5 (enExample)
JP2015199747A (ja) 病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物
Maleki Dizaj et al. Targeting multidrug resistance with antimicrobial peptide-decorated nanoparticles and polymers
JP2014508734A5 (enExample)
JP2018516944A5 (enExample)
EP3829621A1 (en) Engineered hemichannels, engineered vesicles, and uses thereof
JPWO2019156137A5 (enExample)
US20190292226A1 (en) Sap and peptidomimetic compositions for reducing symptoms of inflammation
RU2019126232A (ru) Пептиды и способы для лечения диабета
RU2016152151A (ru) Препарат, содержащий фактор viii и пептиды фактора фон виллебранда
KR20250039426A (ko) 우유 유래 엑소좀 및 이의 용도
ATE399562T1 (de) Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
JP2016520620A5 (enExample)
JP6211169B2 (ja) マイクロニードル
Beaumont et al. LL-37: an immunomodulatory antimicrobial host defence peptide
RU2005127076A (ru) Пептидные ингибиторы токсинов, производные ll-37
WO2017158432A1 (en) Pancreatic fistula occlusion
EA202090802A1 (ru) Пептидная композиция для лечения повреждений, связанных с возбуждающей нейротоксичностью
Falanga et al. Emerging therapeutic agents on the basis of naturally occurring antimicrobial peptides
RU2011133224A (ru) Новые фармацевтические композиции